Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
2,505
Showing 50 of 2,505
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 101 | ASRT | Assertio Holdings, Inc. | 14 | 8 | 79% | +14.4% | +21.0% | +33.3% | -8.0% |
| 102 | KLXE | Klx Energy Services Holdings, Inc. | 45 | 6 | 84% | +14.4% | +13.7% | +59.1% | -27.4% |
| 103 | MIST | Milestone Pharmaceuticals Inc. | 13 | 5 | 100% | +14.3% | +13.4% | +30.1% | +10.8% |
| 104 | ZNTL | Zentalis Pharmaceuticals, Inc. | 147 | 17 | 82% | +14.2% | +15.8% | +64.7% | -150.7% |
| 105 | MEG | Montrose Environmental Group, Inc. | 34 | 6 | 74% | +14.2% | +16.6% | +37.1% | -13.1% |
| 106 | SGMT | Sagimet Biosciences Inc. | 18 | 11 | 100% | +14.0% | +16.4% | +20.6% | +5.3% |
| 107 | LB | Landbridge Co LLC | 21 | 9 | 100% | +13.9% | +14.5% | +15.2% | +5.6% |
| 108 | BHR | Braemar Hotels & Resorts Inc. | 12 | 4 | 83% | +13.9% | +19.5% | +22.2% | -24.1% |
| 109 | MXC | Mexco Energy Corp | 35 | 3 | 83% | +13.8% | +26.4% | +43.9% | -52.2% |
| 110 | LWLG | Lightwave Logic, Inc. | 48/49 | 8 | 71% | +13.7% | +51.1% | +56.0% | -137.9% |
| 111 | EYPT | Eyepoint Pharmaceuticals, Inc. | 122 | 15 | 66% | +13.6% | +23.8% | +42.9% | -45.9% |
| 112 | GALT | Galectin Therapeutics Inc | 90/91 | 7 | 63% | +13.4% | +7.4% | +53.9% | -36.0% |
| 113 | AROC | Archrock, Inc. | 35/38 | 9 | 86% | +13.4% | +12.6% | +23.9% | -10.2% |
| 114 | BLNK | Blink Charging Co. | 67 | 3 | 79% | +13.4% | +18.0% | +30.7% | -17.3% |
| 115 | PLBY | Plby Group, Inc. | 63/76 | 11 | 76% | +13.4% | +17.3% | +33.4% | -87.9% |
| 116 | CHPT | Chargepoint Holdings, Inc. | 351 | 24 | 84% | +13.3% | +7.6% | +45.0% | -40.8% |
| 117 | HUMA | Humacyte, Inc. | 65/67 | 7 | 85% | +13.3% | +13.8% | +41.0% | -14.1% |
| 118 | QTRX | Quanterix Corp | 43 | 7 | 86% | +13.1% | +7.6% | +30.7% | -21.5% |
| 119 | STRZ | Starz Entertainment Corp /Cn/ | 12/21 | 14 | 92% | +13.0% | +15.7% | +18.3% | -5.3% |
| 120 | CURV | Torrid Holdings Inc. | 49 | 18 | 98% | +12.9% | +11.7% | +32.7% | -19.0% |
| 121 | LFVN | Lifevantage Corp | 10 | 4 | 90% | +12.9% | +15.7% | +20.9% | -6.4% |
| 122 | TMQ | Trilogy Metals Inc. | 29/30 | 7 | 45% | +12.8% | -0.6% | +43.9% | -11.4% |
| 123 | TALO | Talos Energy Inc. | 882/885 | 34 | 71% | +12.8% | +9.3% | +41.8% | -41.1% |
| 124 | SLNH | Soluna Holdings, Inc | 69/71 | 10 | 75% | +12.8% | +15.7% | +46.0% | -128.2% |
| 125 | PROK | Prokidney Corp. | 112 | 5 | 60% | +12.8% | +5.2% | +66.9% | -76.0% |
| 126 | OLMA | Olema Pharmaceuticals, Inc. | 105 | 13 | 81% | +12.8% | +10.9% | +47.7% | -51.8% |
| 127 | AHCO | Adapthealth Corp. | 75/76 | 19 | 89% | +12.8% | +8.8% | +27.7% | -6.3% |
| 128 | PLTK | Playtika Holding Corp. | 212 | 14 | 94% | +12.8% | +17.1% | +23.1% | -9.7% |
| 129 | FTRE | Fortrea Holdings Inc. | 34/37 | 5 | 50% | +12.8% | +0.3% | +47.8% | -35.0% |
| 130 | ACTU | Actuate Therapeutics, Inc. | 145 | 28 | 100% | +12.6% | +12.5% | +25.4% | +12.5% |
| 131 | PXMD | Paxmedica, Inc. | 50 | 5 | 48% | +12.3% | -7.2% | +69.3% | -29.5% |
| 132 | ORGN | Origin Materials, Inc. | 38 | 8 | 87% | +12.2% | +10.4% | +43.9% | -19.0% |
| 133 | OMDA | Omada Health, Inc. | 10 | 3 | 70% | +12.2% | +12.9% | +32.1% | -18.3% |
| 134 | RES | Rpc Inc | 43 | 3 | 70% | +12.2% | +22.4% | +37.9% | -28.0% |
| 135 | AMRC | Ameresco, Inc. | 69/74 | 13 | 87% | +12.2% | +14.0% | +52.4% | -50.1% |
| 136 | TWI | Titan International Inc | 18 | 11 | 78% | +12.1% | +17.5% | +25.5% | -5.8% |
| 137 | MNTS | Momentus Inc. | 491 | 8 | 73% | +12.1% | +23.2% | +80.1% | -106.2% |
| 138 | STEM | Stem, Inc. | 105 | 17 | 80% | +12.1% | +14.1% | +44.4% | -33.7% |
| 139 | AIRO | Airo Group Holdings, Inc. | 10 | 5 | 100% | +12.1% | +7.9% | +22.7% | +5.6% |
| 140 | CRWV | Coreweave, Inc. | 8,194/8,883 | 14 | 69% | +12.0% | +11.6% | +47.7% | -70.5% |
| 141 | LGVN | Longeveron Inc. | 15 | 4 | 93% | +12.0% | +13.1% | +26.7% | -4.8% |
| 142 | SGU | Star Group, L.P. | 15 | 3 | 100% | +11.9% | +14.0% | +16.1% | +2.2% |
| 143 | JSPR | Jasper Therapeutics, Inc. | 13 | 6 | 69% | +11.9% | +4.9% | +67.3% | -11.8% |
| 144 | BLTE | Belite Bio, Inc | 102/112 | 4 | 100% | +11.8% | +12.7% | +18.0% | +4.2% |
| 145 | ONEW | Onewater Marine Inc. | 97/101 | 13 | 82% | +11.7% | +15.8% | +30.7% | -30.4% |
| 146 | PACB | Pacific Biosciences of California, Inc. | 58 | 9 | 78% | +11.7% | +12.4% | +36.7% | -28.4% |
| 147 | NMRA | Neumora Therapeutics, Inc. | 21 | 6 | 67% | +11.6% | +27.4% | +42.0% | -44.6% |
| 148 | XOMA | Xoma Corp | 73 | 13 | 100% | +11.6% | +11.9% | +19.7% | +8.6% |
| 149 | GYRE | Gyre Therapeutics, Inc. | 92/102 | 4 | 75% | +11.5% | +13.4% | +38.0% | -31.8% |
| 150 | SAIL | Sailpoint, Inc. | 94/95 | 20 | 85% | +11.5% | +11.8% | +27.3% | -6.4% |